PARKE DAVIS FDA Approval NDA 016680

NDA 016680

PARKE DAVIS

FDA Drug Application

Application #016680

Application Sponsors

NDA 016680PARKE DAVIS

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004

Application Products

001TABLET;ORAL0.03MG;0.0075MG0EUTHROID-0.5LIOTRIX (T4;T3)
002TABLET;ORAL0.06MG;0.015MG0EUTHROID-1LIOTRIX (T4;T3)
003TABLET;ORAL0.12MG;0.03MG0EUTHROID-2LIOTRIX (T4;T3)
004TABLET;ORAL0.18MG;0.045MG0EUTHROID-3LIOTRIX (T4;T3)

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 16680
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.